What The Drug!? — Drug Design Challenge Live Stream

webinar

Thu, 13 Jun 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

What The Drug!? — Drug Design Challenge Live Stream

Great minds do think alike. Or perhaps they don’t? What goes through the mind of a drug hunter when facing a new challenge?

In “What The Drug?!” we will dive into the thought processes, strategies, and problem-solving techniques of medicinal and computational chemists. The concept: No script. At the beginning of the session, a project is disclosed and its aims are defined. What follows is a freestyle design session where compound design decisions are commented on, providing insights into the creative and analytical processes that drive drug discovery. During the whole event, the viewers are openly invited to comment and share their input.

Anything can happen: Tasks such as “Design a nanomolar binder for target X” or “Suggest five novel scaffolds in compound Y” may arise. With the defined goal in mind, we will use BioSolveIT applications to creatively explore solutions from various angles, innovate compound design, and push the boundaries of what’s possible in drug discovery. Science coupled with ingenuity.

Let’s see how much we can achieve live in a given time frame and if the goals can be reached.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on